Renal epithelial gene expression profile and bismuth-induced resistance against cisplatin nephrotoxicity

Human and Experimental Toxicology

Volumn 22, Issue 10, 2003, Pages 535-540

  Leussink, Berend T ^a   Baelde, Hans J ^a   Broekhuizen van den Berg, Thirza M ^a   de Heer, Emile ^a   van der Voet, Gijsbert B ^a   Slikkerveer, Anja ^a,b   Bruijn, Jan A ^a   de Wolff, Frederik A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Bismuth; Cisplatin; Differential gene expression analysis; Nephrotoxicity; Platinum; Renoprotection

Indexed keywords

AMINOPHENOL; BISMUTH; BISMUTH CITRATE; BISMUTH NITRATE; CISPLATIN; CYTOCHROME C OXIDASE; ELONGATION FACTOR 1ALPHA; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; METALLOTHIONEIN; REGULATOR PROTEIN; RIBOSOME PROTEIN; XENOBIOTIC AGENT;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME SUBUNIT; FEMALE; GENE EXPRESSION REGULATION; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; NEPHROTOXICITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0344466405     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327103ht393oa     Document Type: Article

References (38)

1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-402.
2. 3+-pretreatment in the rat in vivo and in vitro. Biochem Pharmacol 1991; 41: 369-75.
3. Burke PV, Poyton RO. Structure/function of oxygen-regulated isoforms in cytochrome c oxidase. J Exp Biol 1998; 201: 1163-75.
4. Creely JJ, Dimari SJ, Howe AM, Haralson MA. Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells. Am J Pathol 1992; 140: 45-55.
5. Cvitkovic E. Cumulative toxicities from cisplatin therapy and current cytoprotective measures. Cancer Treat Rev 1998; 24: 265-81.
6. Cvitkovic E, Spaulding J, Bethune V, Martin J, Whitmore WF. Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer 1977; 39: 1357-61.
7. De Larco JE, Todaro GJ. Epitheliod and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and virus transformation. J Cell Physiol 1978; 94: 335-42.
8. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996; 93, 6025-30.
9. Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999; 49: 156-64.
10. Fotouhi-Ardakani N, Batist G. Genomic cloning and characterization of the rat glutathione S-transferase-A3-subunit gene. Biochem J 1999; 339: 685-93.
11. Hamada T, Nishiwaki Y, Kodama T, Hayashibe A, Nukariya N, Sasaki H, Morikawa T, Hirosawa T, Matsuyama T. Prevention of renal toxicity of cisplatin by administration of bismuth subnitrate. Jpn J Cancer Chemother 1989; 16: 3587-93.
12. Hayes DM, Cvitkovic E, Golbey RB, Scheiner E, Helson L, Krakoff IH. High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Cancer 1977; 39: 1372-81.
13. Kondo Y, Satoh M, Imura N, Akimoto M. Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor. Cancer Chemother Pharmacol 1991; 29: 19-23.
14. Kondo Y, Satoh M, Imura N, Akimoto M. Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor. Anticancer Res 1992; 12: 2303-308.
15. Kuhlmann MK, Burkhardt G, Köhler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997; 12: 2478-80.
16. Lee S, Ann DK, Wang E. Cloning of human and mouse brain cDNAs coding for S1, the second member of the mammalian elongation factor-1 alpha gene family: analysis of a possible evolutionary pathway. Biochem Biophys Res Commun 1994; 203: 1371-77.
17. Leussink BT, Nagelkerke JF, van de Water B, Slikkerveer A, van der Voet GB, Srinivasan A, Bruijn JA, De Wolff FA, de Heer E. Pathways of proximal tubular cell death in bismuth nephrotoxicity. Toxicol Appl Pharmacol 2002; 180: 100-109.
18. Leussink BT, Slikkerveer A, Engelbrecht MRW, van der Voet GB, Nouwen EJ, de Heer E, De Broe ME, De Wolff FA, Bruijn JA. Bismuth overdosing-induced reversible nephropathy in rats. Arch Toxicol 2001; 74: 745-54.
19. Leussink BT, Slikkerveer A, Krauwinkel WJ, van der Voet GB, de Heer E, De Wolff FA, Bruijn JA. Bismuth biokinetics and kidney histopathology after bismuth overdose in rats. Arch Toxicol 2000; 74: 349-55.
20. Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, Johnson DR, Klaassen CD, Waalkes MP. Overexpression of glutathione s-transferase ii and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol 2001; 60: 302-309.
21. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000; 405: 827-36.
22. Madias NE, Harrington JT. Platinium nephrotoxicity. Am J Med 1978; 65: 307-14.
23. Meyer KB, Madias NE. Cisplatin nephrotoxicity. Miner Electrol Metab 1994; 20: 201-13.
24. Moine H, Bienaime C, Mougel M, Reinbolt J, Ebel JP, Ehresmann C, Ehresmann B. Crosslinking of ribosomal protein S18 to 16 S RNA in E.coli ribosomal 30 S subunits by the use of a reversible crosslinking agent: trans-diamminedichloroplatinum(II). FEBS Lett 1988; 228: 1-6.
25. Musio F, Carome MA, Bohen EM, Sabnis S, Yuan CM. Effect of glycine on cisplatin nephrotoxicity and heat-shock protein 70 expression in the rat kidney. Ren Fail 1997; 19: 33-46.
26. Naganuma A, Satoh M, Imura N. Prevention of lethal and renal toxicity of cis-CCP(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res 1987; 47: 983-87.
27. O'Malley K, Mauron A, Barchas JD, Kedes L. Constitutively expressed rat mRNA encoding a 70-kilodalton heat-shock- like protein. Mol Cell Biol 1985; 5: 3476-83.
28. Rasmussen NJ, Wikman FP, Clark BF. Crosslinking of tRNA containing a long extra arm to elongation factor Tu by trans-diamminedichloroplatinum(II). Nucleic Acids Res 1990; 18: 4883-90.
29. Satoh M, Shimada A, Zhang B, Tohyama C. Renal toxicity caused by cisplatinum in glutathione-depleted metallothionein-null mice. Biochem Pharmacol 2000; 60: 1729-34.
30. Slikkerveer A, De Wolff FA. Pharmacokinetics and toxicity of bismuth compounds. Med Toxicol Exp Drug 1989; 4: 303-23.
31. Slikkerveer A, Helmich RB, Der Voet GB, De Wolff FA. Absorption of bismuth from several bismuth compounds during in vivo perfusion of rat small intestine. J Pharm Sci 1995; 84: 512-15.
32. Sommer S, Thorling EB, Jakobsen A, Steiness E, Ostergaard K. Can bismuth decrease the kidney toxic effects of cis-platinum? Eur J Cancer Clin Oncol 1989; 25: 1903-904.
33. Suzuki E, Hirata Y, Hayakawa H, Omata M, Kangawa K, Minamino N, Matsuo H. Evidence for C-type natriuric peptide production in the rat kidney. Biochem Biophys Res Commun 1997; 192: 532-38.
34. Suzuki K, Olvera J, Wool IG. The primary structure of rat ribosomal protein S7. FEBS Lett 1990; 271: 51-53.
35. Suzuki K, Wool IG. The primary structure of rat ribosomal protein L17. Biochem Biophys Res Commun 1991; 178: 322-28.
36. Villani G, Attardi G. In vivo control of respiration by cytochrome c oxidase in human cells. Free Rad Biol Med 2000; 29, 202-10.
37. Walker C, Everitt J, Freed JJ Jr, Knudson AG, Whitely LO. Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma. Cancer Res 1991; 51, 2973-78.
38. Zhang H, Xu Q, Krajewski S, Krajewska M, Xie Z, Fuess S, Kitada S, Godzik A, Reed JC. BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci USA 2000; 97: 2597-602.